GAULT CHERYL (Chief Operating Officer) sold 6.7% of their position (10K shares) of RAPPORT THERAPEUTICS, INC. on the open market
Open‑market sale worth $331.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/1/2026ACC: 0001193125-26-410734
Officer· Chief Operating Officer
Since Mar 2026
-10K
Net shares
Net seller
$331.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
10K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−7.92K
Price / share
$33.04
Trade value
$261.81K
% of position
5.3%
9/30/2026
149.91K→141.99K
Common Stock
Direct
Shares
−2.08K
Price / share
$33.76
Trade value
$70.04K
% of position
1.5%
9/30/2026
141.99K→139.91K
Total
Net shares
−10K
Net value
-$331.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/30/2026 | S · Sale | −7.92K | $33.04 | $261.81K | 5.3% | 149.91K | 141.99K |
| Common Stock Direct | 9/30/2026 | S · Sale | −2.08K | $33.76 | $70.04K | 1.5% | 141.99K | 139.91K |
| Total | −10K | -$331.86K | ||||||
Derivative Transactions0
No derivative transactions reported